Literature DB >> 551514

Laboratory procedures for cases of suspected infant botulism.

C L Hatheway.   

Abstract

The recent development and evaluation of procedures for examination of fecal specimens for botulinal toxin and Clostridium botulinum have provided the means by which infant botulism can be recognized. The toxicity for mice of fecal extracts containing botulinal toxin can be neutralized with specific botulinal antitoxin. The presence of C. botulinum in the feces is detected by demonstrating the presence of botulinal toxin in enrichment culture supernatant by means of toxicity tests in mice. C. botulinum is isolated by streaking enrichment cultures on egg yolk agar and picking typical lipase-positive colonies. The experience of both the Center for Disease Control (CDC) Botulism Laboratory and other laboratories has been that botulinal toxin and C. botulinum are rarely, if ever, found in the feces of humans (infants or older people) not afflicted with botulism. Results of the examination in the CDC laboratory of specimens from 24 babies with infant botulism are given.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 551514     DOI: 10.1093/clinids/1.4.647

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  16 in total

Review 1.  Update: infant botulism.

Authors:  T F Midura
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

2.  Evaluation of fluorescent-antibody tests as a means of confirming infant botulism.

Authors:  C Glasby; C L Hatheway
Journal:  J Clin Microbiol       Date:  1984-12       Impact factor: 5.948

3.  Purification and characterization of neurotoxin complex from a dual toxin gene containing Clostridium Botulinum Strain PS-5.

Authors:  Ajay K Singh; Amita Sachdeva; Jeffrey A Degrasse; Timothy R Croley; Larry H Stanker; David Hodge; Shashi K Sharma
Journal:  Protein J       Date:  2013-04       Impact factor: 2.371

4.  Examination of feces and serum for diagnosis of infant botulism in 336 patients.

Authors:  C L Hatheway; L M McCroskey
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

5.  Detection of Clostridium botulinum type A toxin by enzyme-linked immunosorbent assay with antibodies produced in immunologically tolerant animals.

Authors:  M Dezfulian; J G Bartlett
Journal:  J Clin Microbiol       Date:  1984-05       Impact factor: 5.948

6.  Serum antibody response to Clostridium botulinum toxin in infant botulism.

Authors:  L G Rubin; M Dezfulian; R H Yolken
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

7.  Characterization of an organism that produces type E botulinal toxin but which resembles Clostridium butyricum from the feces of an infant with type E botulism.

Authors:  L M McCroskey; C L Hatheway; L Fenicia; B Pasolini; P Aureli
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

8.  Quantitation of Clostridium botulinum organisms and toxin in the feces of an infant with botulism.

Authors:  J C Paton; A J Lawrence; J I Manson
Journal:  J Clin Microbiol       Date:  1982-01       Impact factor: 5.948

9.  Isolation of an organism resembling Clostridium barati which produces type F botulinal toxin from an infant with botulism.

Authors:  J D Hall; L M McCroskey; B J Pincomb; C L Hatheway
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

10.  Selective medium for isolation of Clostridium botulinum from human feces.

Authors:  M Dezfulian; L M McCroskey; C L Hatheway; V R Dowell
Journal:  J Clin Microbiol       Date:  1981-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.